Teva markets fremanezumab. The Patient Information Leaflet for fremanezumab from Teva can be downloaded from the Health Products Regulatory Authority (HRPA) website. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email or telephone: +44 (0) 207 540 7117.
Brand names for Fremanezumab: AJOVY®▼
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the HRPA website for more details.
Pack size: 1
Understanding how AJOVY® works:
This video can help you understand what causes migraines and how your treatment works. For further information about migraine and your treatment, please check your patient information leaflet.
How to inject AJOVY®:
Please read your patient information leaflet carefully before you start using this medicine because it contains important information for you, including step by step instructions on how to administer your AJOVY® injection. You should not inject yourself until you have been trained by your doctor or nurse. You should also contact them if you have any further questions.
Rain Free Days™
Rain Free Days™ is a Patient Support Programme app for patients prescribed AJOVY®,
developed with input from patients with migraine. Download a copy of the app from the Apple or Google Play store (Product batch code verification is required)
Information on Teva products
For Teva products, our Patient Information Leaflets (PILs) are available to download from the HPRA website https://www.hpra.ie. If you are still having difficulty or have any questions regarding your medication please contact us at tel: +44 207 540 7117 or via email: firstname.lastname@example.org
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the HRPA website. By reporting side effects you can help provide more information on the safety of a medicine.